Cumberland Pharmaceuticals to Announce Second Quarter 2011 Financial Results on August 4, 2011
NASHVILLE, Tenn., July 14, 2011 /PRNewswire/ – Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced today that it will release second quarter 2011 financial results after the market closes on Thursday, August 4, 2011. A conference call and live Internet webcast will be held on Thursday, August 4, 2011, at 5:00 p.m. Eastern Time to discuss the results.
To participate in the call, please dial 877-303-1298 (for U.S. callers) or 253-237-1032 (for international callers). A rebroadcast of the teleconference will be available for one week and can be accessed by dialing 855-859-2056 (for U.S. callers) or 404-537-3406 (for international callers). The Conference ID for the rebroadcast is 83958714. The live webcast and rebroadcast can be accessed via Cumberland’s website at http://investor.shareholder.com/cpix/events.cfm.
Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. The Company’s primary target markets include hospital acute care and gastroenterology. Cumberland’s marketed products include AcetadoteÃ‚® (acetylcysteine) Injection for the treatment of acetaminophen poisoning, CaldolorÃ‚® (ibuprofen) Injection, the first injectable treatment for pain and fever approved in the United States, and KristaloseÃ‚® (lactulose) for Oral Solution, a prescription laxative. Cumberland is dedicated to providing innovative products that improve quality of care for patients. For more information on Cumberland, please visit the Company’s website at www.cumberlandpharma.com.
SOURCE Cumberland Pharmaceuticals Inc.